Total Voting Rights

Summary by AI BETAClose X

NatWest Group plc has notified the market of its total voting rights and issued share capital as of November 28, 2025. The company has 8,015,013,316 ordinary shares issued, excluding treasury shares, each carrying four voting rights, resulting in 32,060,053,264 total voting rights for ordinary shares. Additionally, there are 230,155,278 ordinary shares held in treasury with non-exercisable voting rights, and a combined total of 483,140 preference shares with 962,744 and 969,816 voting rights respectively. The total number of voting rights for shareholders to use for disclosure calculations is 32,061,985,824.

Disclaimer*

NatWest Group plc
28 November 2025
 


NatWest Group plc

Total Voting Rights and Capital

In conformity with the Disclosure Guidance and Transparency Rules, NatWest Group plc ("NWG") hereby notifies the following in respect of its issued share capital with voting rights as at

28 November 2025.

 

Share Class and nominal value

Number of Shares issued

Voting rights per share

Total Voting rights

28 November 2025

Ordinary Shares of £1.0769* (excluding ordinary shares held in treasury)

8,015,013,316

 

 

4

32,060,053,264

Ordinary Shares of £1.0769* held in treasury

 

230,155,278

4

Voting rights not exercisable

11% Cumulative Preference Shares of £1

 

240,686

 

4

 

962,744

5.5% Cumulative Preference Shares of £1

 

242,454

 

4

 

969,816

 Total:

 

       8,245,651,734

 

                                                 

             32,061,985,824

* Note: the nominal value of Ordinary Shares without rounding is £1.076923,076923077 per share

 

Shareholders may use the above figure of 32,061,985,824 for their calculations to determine whether they are required to notify their interest in, or a change to their interest in, NWG under the FCA's Disclosure Guidance and Transparency Rules.

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90     

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings